Market need Opportunity to sell a wearable external device leveraging neuromodulation for premature ejaculation, addressing a large unmet need in male sexual health with a potential consumer and clinical study angle.

Early traction Recent launch of MOR patch and ongoing research partnerships suggest a path to market readiness and credibility; target channels include medical clinics, sexual health specialists, and direct-to-consumer education.

Partnership potential Attrac­t with San Diego Sexual Medicine and other urology/sexology clinics for efficacy studies and pilot programs to validate product claims and generate clinical data for adoption by providers.

Affordability path Small team with sub-$1M revenue and modest funding presents an opportunity for cost-effective pilots, channel partnerships, and clinical reimbursement conversations as the product scales.

Competitive positioning Distinct neuromodulation wearable/patch approach can differentiate Morari from traditional therapies; leverage clinical study results and patient education to compete with larger medical device players in sexual wellness.